Autoantibodies-Abzymes with Phosphatase Activity in Experimental Autoimmune Encephalomyelitis Mice

Andrey E Urusov1,2, Kseniya S Aulova1, Georgy A Nevinsky1,2

  • 1Institute of Chemical Biology and Fundamental Medicine, SB of the Russian Academy of Sciences, Lavrentiev Ave., 8, 630090 Novosibirsk, Russia.

PubMed

Insights

This study reveals that immunoglobulin G (IgG) phosphatase activity significantly increases during experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis. This heightened activity, particularly at specific pH levels, is linked to disease progression and suggests a key role for IgG in EAE pathogenesis.

Area of Science:

  • Immunology
  • Biochemistry
  • Neuroscience

Background:

  • The precise mechanisms driving multiple sclerosis (MS) progression remain elusive.
  • Experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice serves as a model for human MS.
  • EAE development involves altered bone marrow hematopoietic stem cell differentiation, producing autoantibodies against myelin basic protein (MBP), mouse oligodendrocyte glycoprotein (MOG), histones, DNA, and RNA.

Purpose of the Study:

  • To investigate the changes in relative phosphatase activity of immunoglobulin G (IgG) in C57BL/6 mice during different stages of EAE.
  • To determine the optimal pH conditions for IgG phosphatase activity in the context of EAE.
  • To explore the correlation between IgG phosphatase activity and EAE development following immunization and treatment.

Main Methods:

  • Analysis of IgG phosphatase activity in mouse blood sera across EAE onset, acute, and remission phases.
  • Assay of IgG's catalytic hydrolysis of *p*-nitrophenyl phosphate at various pH values.
  • Monitoring of phosphatase activity changes after immunization with DNA-histone complex and treatment with MOG during EAE.

Main Results:

  • IgG exhibited optimal phosphatase activity at pH 6.5-7.0 and 8.5-9.5.
  • During spontaneous EAE, activity at pH 6.5 increased, while activity at pH 8.8 decreased between 50 and 100 days.
  • Immunization and MOG treatment markedly elevated IgG phosphatase activity, correlating with accelerated EAE development and increased lymphocyte production of these antibodies.

Conclusions:

  • IgG phosphatase activity demonstrates significant alterations during the spontaneous and induced development of EAE.
  • The observed changes in IgG phosphatase activity, particularly its increase under specific conditions, suggest a critical role in the pathogenesis of EAE.
  • Further research into IgG phosphatase activity could offer insights into MS mechanisms and potential therapeutic targets.

Related Concept Videos